Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease-Reference-Cited by-同舟云学术

Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease

Published:2019-07 Issue: Volume:64 Page:175-180
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Hauser Robert A.,Isaacson Stuart H.,Ellenbogen Aaron,Safirstein Beth E.,Truong Daniel D.^ORCID,Komjathy Steven F.,Kegler-Ebo Deena M.,Zhao Ping,Oh Charles

Funder

Acorda Therapeutics, Inc

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference23 articles.

1. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease;Ferreira;Eur. J. Neurol.,2013

2. Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatments;Encarnacion;Eur. Neurol.,2008

3. The scientific and clinical basis for the treatment of Parkinson disease;Olanow;Neurology,2009

4. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations;Jankovic;Mov. Disord.,2005

5. The spectrum of "off" in Parkinson's disease: what have we learned over 40 years?;Chou;Park. Relat. Disord.,2018

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early-morning OFF in Parkinson’s disease: A systematic literature review and current therapeutics;Clinical Neurology and Neurosurgery;2024-10

2. Hope vs. Hype III: Rescue/on-demand therapies are preferable to device-assisted therapies in Parkinson disease;Parkinsonism & Related Disorders;2024-09

3. Levodopa inhalada: de la evidencia a la experiencia;Revista de Neurología;2024

4. Too little or too much nocturnal movements in Parkinson’s disease: A practical guide to managing the unseen;Clinical Parkinsonism & Related Disorders;2024

5. Medical, surgical, and physical treatments for Parkinson's disease;The Lancet;2024-01